Calixar
A world reference in the production of membrane proteins targets for drug and vaccine discovery.
Launch date
Employees
Market cap
-
Enterprise valuation
$11—17m (Dealroom.co estimates Mar 2020.)
Company register number 530424670
Lyon Auvergne-Rhône-Alpes (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | €880k | Seed | |
€1.0m | Series B | ||
* | N/A | €2.5m | Late VC |
* | N/A | Acquisition | |
| Total Funding | $4.8m | ||
Related Content
Recent News about Calixar
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.